Jun . 05, 2026 10:36 Back to list
Enterovirus infections remain a significant global public health concern, especially in pediatric populations where symptoms can escalate rapidly and lead to severe complications. Early detection is critical for controlling transmission, guiding clinical treatment, and preventing outbreaks in community and hospital settings. Reliable molecular diagnostic tools are therefore essential for modern healthcare systems.
Cowin Gene is dedicated to advancing molecular POCT (Point-of-Care Testing) technology, offering clinicians and patients fast, easy-to-use, and highly sensitive diagnostic solutions. Its PCR-based core product portfolio enables rapid detection of a wide range of pathogens, including viruses, bacteria, and fungi, helping improve diagnostic efficiency across clinical environments.
With a strong team of senior scientists, engineers, and marketing professionals, Cowin Gene continuously focuses on technological innovation and product optimization. Its R&D center is equipped with state-of-the-art laboratory instruments and operates under a strict quality management system to ensure all products meet international in vitro diagnostic standards. The company is committed to becoming a global leader in molecular POCT, providing fast and reliable diagnostic solutions to improve healthcare worldwide.

The Cowingene Enterovirus Detection Kit (Lyophilized) is an in vitro diagnostic (IVD) assay designed for the qualitative detection of Enterovirus RNA in clinical specimens. It utilizes real-time PCR technology to ensure accurate and sensitive detection, enabling clinicians to identify infections quickly and efficiently.
This lyophilized format significantly enhances reagent stability, allowing storage at 2–30°C for up to 18 months. This eliminates the need for strict cold-chain logistics and makes the kit highly suitable for a wide range of laboratory environments, including those in resource-limited regions.
By targeting Enterovirus specifically, the kit provides a focused and reliable diagnostic solution for gastrointestinal and systemic infections associated with viral outbreaks.
This high-sensitivity PCR detection kit is designed for clinical laboratories requiring accurate and reproducible enterovirus detection. With a limit of detection (LoD) of 400 copies/mL, it ensures reliable performance even in samples with low viral load.
The kit supports validated specimen types including feces and vomit, making it particularly useful for diagnosing gastrointestinal infections. The collected samples should be processed as soon as possible; if immediate testing is not feasible, they can be stored at 2–8°C for up to 7 days, below -18°C for up to 6 months, and below -70°C for long-term preservation.
Cowin Gene’s strict quality control system ensures consistent reagent performance across batches, supporting high diagnostic accuracy and reproducibility in clinical practice.
One of the key advantages of this lyophilized enterovirus detection kit is its excellent stability at room temperature conditions. The reagents can be stored at 2–30°C for up to 18 months, making it highly convenient for transportation, storage, and field deployment.
This stability reduces reliance on cold-chain logistics, lowering operational costs and expanding accessibility to molecular diagnostics in remote and underserved areas. It is particularly valuable for decentralized healthcare systems and outbreak response scenarios where rapid deployment is critical.
The kit maintains high sensitivity and specificity even after extended storage, ensuring reliable diagnostic outcomes without compromising performance
This advanced molecular diagnostic kit is designed for rapid screening of enterovirus infections in clinical and public health settings. It uses real-time PCR amplification technology to deliver accurate and timely results, supporting early intervention and outbreak control.
The lyophilized reagent format improves operational flexibility by simplifying storage and transportation requirements. Once opened, Buffer Lyobeads remain stable for up to 7 days at 2–8°C, while PCR components maintain stability for up to 1 month at -20°C under proper conditions.
Strict handling procedures, including protection from light and controlled freeze-thaw cycles, ensure optimal reagent performance and consistent diagnostic accuracy.
Cowin Gene’s molecular POCT products provide significant advantages in clinical diagnostics, including rapid detection time, simplified operation procedures, and high sensitivity performance. These characteristics make them highly suitable for hospitals, diagnostic laboratories, and infectious disease control centers.
The company’s core product line is based on PCR technology, enabling the rapid detection of multiple pathogen types such as viruses, bacteria, and fungi. Each product is developed under a strict quality management system to ensure compliance with international in vitro diagnostic standards.
The Cowingene Enterovirus Detection Kit (Lyophilized) is supported by recommended extraction reagents such as viral DNA/RNA columns and nucleic acid extraction kits, ensuring a complete and optimized workflow from sample preparation to final detection.
Cowin Gene continues to invest in research and development to advance molecular POCT technology. With a strong vision of becoming a global innovation leader in in vitro diagnostics, the company is committed to delivering fast, reliable, and accessible diagnostic solutions that improve human health worldwide and support global disease prevention efforts.
Related PRODUCTS
Meet COWIN GENE at WHX Bangkok 2026!
NewsJun.09,2026Supporting Ebolavirus Surveillance with Real-time PCR Detection
NewsMay.27,20267 Days To Go Until Whx Lagos 2026!
NewsMay.26,2026Compact Molecular Testing for Accurate Malaria Detection
NewsJul.20,2026Comprehensive HPV Genotyping. Reliable Molecular Diagnostics
NewsJul.17,2026Rapid Molecular Detection of EV71 & CoxA16 with High Stability Lyophilized PCR Kit
NewsJul.16,2026